About Alpharmaca

Alpharmaca Inc. has long been dedicated to the field of nanoscience and nanotechnology, providing comprehensive solutions for nanomaterial production, particle characterization, application development, and analytical optimization.

The Nicomp series particle sizeus, trace their origin back to the 1980s, when they became the first instruments to commercialize Dynamic Light Scattering (DLS) technology. Over the decades, the Nicomp line earned global recognition for its precision and innovation in nanoparticle analysis. Its unique features - including baseline adjustment for automatic aggregate compensation and a proprietary high-resolution multimodal algorithm - established its reputation among leading scientists worldwide for the ability to resolve close bimodal distributions and differentiate native particles from aggregate tails.

In 2025, Alpharmaca Inc, officially assumed operational responsibility for the Nicomp product line from Entegris, marking the beginning of a new chapter that combines Nicomp's proven DLS technology with Alpharmaca's deep expertise in nanoscience, driving continuous innovation and excellence in nanoparticle characterization.